A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
-
Published:2022-11
Issue:
Volume:175
Page:110-119
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Climent Miguel A.,
Font Albert,
Durán Ignacio,
Puente Javier,
José Méndez-Vidal María,
Sáez María Isabel,
Santander Lobera Carmen,
Ángel Arranz Arija Jóse,
González-del-Alba AranzazuORCID,
Sánchez-Hernandez AlfredoORCID,
Juan Fita Maria Jose,
Esteban EmilioORCID,
Alonso-Gordoa Teresa,
Mellado Gonzalez Begoña,
Maroto Pablo,
Lázaro-Quintela MartínORCID,
Cassinello-Espinosa Javier,
Pérez-Valderrama Begoña,
Garcias Carmen,
Castellano Daniel
Subject
Cancer Research,Oncology
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献